CME Group Inc. $CME Shares Sold by Mesirow Financial Investment Management Inc.

Mesirow Financial Investment Management Inc. decreased its holdings in CME Group Inc. (NASDAQ:CME) by 19.0% in the 4th quarter, HoldingsChannel reports. The firm owned 15,781 shares of the financial services provider’s stock after selling 3,700 shares during the quarter. Mesirow Financial Investment Management Inc.’s holdings in CME Group were worth $4,309,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Empowered Funds LLC raised its position in shares of CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after buying an additional 1,037 shares in the last quarter. Marshall Wace LLP boosted its holdings in shares of CME Group by 103.1% in the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after acquiring an additional 121,707 shares in the last quarter. Federated Hermes Inc. increased its stake in shares of CME Group by 1,325.2% during the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after acquiring an additional 21,918 shares during the period. Nebula Research & Development LLC bought a new stake in CME Group during the second quarter worth approximately $992,000. Finally, The Manufacturers Life Insurance Company raised its holdings in CME Group by 2.6% during the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after purchasing an additional 7,397 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group announced plans to launch Nasdaq CME Crypto Index futures on June 8, expanding its regulated crypto offerings and potentially driving additional trading activity. CME Group to Launch Nasdaq CME Crypto Index Futures
• Positive Sentiment: The new futures product is CME’s first market-cap weighted contract, which could broaden participation from both institutional and active retail traders. CME Group to Launch Nasdaq CME Crypto Index Futures
• Positive Sentiment: Interactive Brokers also said it will integrate CME Group event contracts into a unified prediction-market platform, which may improve distribution and accessibility for CME-linked products. Interactive Brokers Rolls Out Centralized Prediction Market Trading Hub with Kalshi Partnership
• Neutral Sentiment: CME Group also released preliminary annual meeting results, including board elections, but the update appears routine and is unlikely to materially affect the stock. CME Group Inc. Announces Preliminary Results of 2026 Annual Meeting
• Neutral Sentiment: Recent analyst commentary remains moderately constructive, but does not appear to be the main driver of the move. Do Wall Street Analysts Like CME Group Stock?

Insider Activity

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of the stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the transaction, the general counsel owned 7,192 shares in the company, valued at $2,397,597.04. This trade represents a 31.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 4,200 shares of CME Group stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $309.65, for a total value of $1,300,530.00. Following the completion of the transaction, the director directly owned 43,007 shares in the company, valued at $13,317,117.55. This represents a 8.90% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 7,791 shares of company stock valued at $2,489,421 over the last three months. Insiders own 0.30% of the company’s stock.

CME Group Trading Up 0.2%

CME Group stock opened at $297.70 on Friday. The firm has a market cap of $107.87 billion, a price-to-earnings ratio of 25.40, a price-to-earnings-growth ratio of 3.59 and a beta of 0.23. CME Group Inc. has a 1 year low of $257.17 and a 1 year high of $329.16. The firm’s 50 day moving average price is $298.49 and its two-hundred day moving average price is $287.99. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.80 EPS. On average, research analysts predict that CME Group Inc. will post 12.26 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s dividend payout ratio is currently 44.37%.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on CME shares. JPMorgan Chase & Co. increased their price target on CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research note on Thursday, April 16th. Royal Bank Of Canada upped their price objective on CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a report on Thursday, February 5th. The Goldman Sachs Group decreased their target price on CME Group from $275.00 to $267.00 and set a “sell” rating for the company in a research note on Thursday, April 23rd. Piper Sandler lifted their target price on CME Group from $313.00 to $329.00 and gave the stock an “overweight” rating in a report on Wednesday, April 15th. Finally, Wall Street Zen cut shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, April 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $305.29.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.